Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Occupational and Environmental Medicine|August 20, 2021
Sleep duration and sleep efficiency in UK long-distance heavy goods vehicle driversAron Peter Sherry, Stacy A Clemes, Yu-Ling Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2024
Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary AdenomasSunita M C De Sousa, Ann McCormack, Andreas Orsmond, et al.
Canadian Journal of Kidney Health and Disease|October 9, 2024
Pregnancy Outcomes in Living Kidney Donors: Protocol of a Population-Based Cohort Study in Three Canadian ProvincesCarol Wang, Kyla L Naylor, Eric McArthur, et al.
The Clinical Neuropsychologist|June 4, 2025
Evaluating evidence for a neuropsychological toolkit to predict cognitive decline in PD: A systematic reviewDana Pourzinal, James King, Kumareshan Sivakumaran, et al.
JMIR Mental Health|October 27, 2022
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation StudyRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Pediatrics|July 3, 2003
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infectionSharon Nachman, Soyeon Kim, James King, et al.
Frontiers in Endocrinology|December 11, 2023
<i>PAM</i> variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomasSunita M C De Sousa, Angeline Shen, Christopher J Yates, et al.
Elife|July 3, 2025
Assemblies, synapse clustering, and network topology interact with plasticity to explain structure-function relationships of the cortical connectomeAndrás Ecker, Daniela Egas Santander, Marwan Abdellah, et al.
International Psychogeriatrics|May 13, 2025
Diagnosis, evaluation & management of cognitive disorders in Parkinson's disease: A systematic reviewDana Pourzinal, Charlotte Elgey, Daniel X Bailey, et al.
NPJ Vaccines|March 20, 2021
Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adultsChristine M Oshansky, James King, Di Lu, et al.
Pageof 15